Berry Street Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-87,500
Closed -$8.13M 113
2021
Q4
$8.13M Buy
+87,500
New +$5.76M 0.84% 32

Berry Street Capital Management's ARNA Position: Q1 2022 in Review

Berry Street Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 87,500 shares — an estimated $8.13M sold.

Berry Street Capital Management first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $8.13M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Berry Street Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Berry Street Capital Management sold 87,500 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $8.13M.
  • Berry Street Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • Berry Street Capital Management's Arena Pharmaceuticals Inc position peaked at $8.13M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Berry Street Capital Management's 13F filing for Q1 2022, filed 13 May 2022.